Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease…
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…
Pursuant to Article 241-2 of the General Regulations of the French Financial Markets Authority (Autorité des marchés financiers – the…
ABINGDON, England, Feb. 6, 2026 /PRNewswire/ -- Infineum, a global leader in specialty chemicals for lubricants and fuels, has launched its…
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…
Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…
ISLAMABAD, Pakistan, Dec. 12, 2025 /PRNewswire/ -- HTX, one of the world's leading digital asset exchanges with over 50 million…
10 December 2025 - The first set of qualification systems for the LA28 Olympic Games has been approved by the International Olympic…
November 13, 2025 18:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Eisai…
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…